Richard Santos, Allison N Boyd, Todd A Walroth, Alexandria Hall, Jessie King, Aileen Ahiskali, Ellen Walter, Nichole Neumann, Dominick Curry, Brittany Hoyte, Wendy Thomas, Beatrice Adams, Nicolas Tran, Vanessa M Gleason, Zachary Drabick, Alexandra DeWitt, Justin Suarez, Ann Marie B Prazak, Kathryn A Disney, David Hill
Vancomycin is a glycopeptide antibiotic that requires close therapeutic monitoring. Prolonged exposure to elevated concentrations increases risk for serious adverse effects such as nephrotoxicity. However, sub-therapeutic concentrations may lead to bacterial resistance and clinical failure or death. The most recent Infectious Diseases Society of America (IDSA) publication regarding therapeutic monitoring of vancomycin recommends utilizing area under the curve (AUC)-based monitoring to maximize clinical success...
June 20, 2024: Journal of Burn Care & Research: Official Publication of the American Burn Association